Home / SFOSF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SFOSF make money? Does SFOSF have pricing power? What's the Earnings Whisper? Will SFOSF profit more as the business scales? What is SFOSF's management track record? Is SFOSF's current price justified?

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

$1.93 -$0.85 (-30.50%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$2.2

Day Range

$1.93$2.2

Year Range

$1.93$3.5

Market Cap

5.11B

AVG Volume

225

Trailing/Forward PE

17.15/1.14

PEG ratio

1.44

Dividend Yield

1.78%

Next Earnings Date

2027-03-29

Primary Exchange

Other OTC

Revenue (CNY)

SFOSF Revenue (CNY) by quarter
Period	Revenue (CNY)
26 Q2	20.1B
26 Q1	10.07B
25 Q4	21.71B
25 Q3	9.88B
25 Q2	10.09B
25 Q1	9.42B
24 Q4	10.16B
24 Q3	10.45B
24 Q2	10.23B
24 Q1	10.06B

Net Income (CNY)

SFOSF Net Income (CNY) by quarter
Period	Net Income (CNY)
26 Q2	1.7B
26 Q1	870.83M
25 Q4	1.64B
25 Q3	821.33M
25 Q2	937.21M
25 Q1	764.76M
24 Q4	759.24M
24 Q3	785.84M
24 Q2	615.06M
24 Q1	609.73M

Operating Income (CNY)

SFOSF Operating Income (CNY) by quarter
Period	Operating Income (CNY)
26 Q2	1.25B
26 Q1	1.38B
25 Q4	1.36B
25 Q3	1.15B
25 Q2	1.4B
25 Q1	1.36B
24 Q4	1.14B
24 Q3	1.18B
24 Q2	680.04M
24 Q1	904.51M

EBITDA (CNY)

SFOSF EBITDA (CNY) by quarter
Period	EBITDA (CNY)
26 Q2	3.07B
26 Q1	1.59B
25 Q4	3.36B
25 Q3	1.39B
25 Q2	1.93B
25 Q1	1.68B
24 Q4	1.46B
24 Q3	1.82B
24 Q2	1.52B
24 Q1	1.79B

Cash Flows (CNY)

SFOSF Cash Flows (CNY) by quarter
Period	Cash Flows (CNY)
26 Q2	-62.14M
26 Q1	57.23M
25 Q4	551.55M
25 Q3	153.13M
25 Q2	123.01M
25 Q1	-62.92M
24 Q4	107.1M
24 Q3	146.04M
24 Q2	247.9M
24 Q1	-198.53M

EPS (CNY)

SFOSF EPS (CNY) by quarter
Period	EPS (CNY)
26 Q2	0.65
26 Q1	0.33
25 Q4	0.62
25 Q3	0.31
25 Q2	0.35
25 Q1	0.29
24 Q4	0.29
24 Q3	0.3
24 Q2	0.23
24 Q1	0.23

Expenses (CNY)

SFOSF Expenses (CNY) by quarter
Period	Expenses (CNY)
26 Q2	6.77B
26 Q1	5.26B
25 Q4	1B
25 Q3	8.4B
25 Q2	1.88B
25 Q1	4.96B
24 Q4	-884.19M
24 Q3	8.32B
24 Q2	4.63B
24 Q1	5.34B

Cash & Debt (CNY)

SFOSF Cash & Debt (CNY) by quarter
Period	Cash & Debt (CNY)
26 Q2	16.32B
26 Q1	15.29B
25 Q4	15.78B
25 Q3	11.48B
25 Q2	15.64B
25 Q1	16.07B
24 Q4	16.12B
24 Q3	15.63B
24 Q2	16.1B
24 Q1	15.02B

Debt ratios

SFOSF Debt ratios by quarter
Period	Debt ratios
26 Q2	2.46
26 Q1	2
25 Q4	2.5
25 Q3	3.91
25 Q2	2.41
25 Q1	2.47
24 Q4	2.36
24 Q3	2.25
24 Q2	3.35
24 Q1	3.11

Margins

SFOSF Margins by quarter
Period	Margins
26 Q2	49.51%
26 Q1	49.7%
25 Q4	51.63%
25 Q3	48.56%
25 Q2	48.45%
25 Q1	47.77%
24 Q4	46.08%
24 Q3	48.07%
24 Q2	43.95%
24 Q1	49.55%

Return on Capital

SFOSF Return on Capital by quarter
Period	Return on Capital
26 Q2	2.68%
26 Q1	1.37%
25 Q4	2.65%
25 Q3	1.35%
25 Q2	1.55%
25 Q1	1.26%
24 Q4	1.27%
24 Q3	1.33%
24 Q2	1.04%
24 Q1	1.06%

Shares Outstanding

SFOSF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	2.64B
26 Q1	2.64B
25 Q4	2.64B
25 Q3	2.65B
25 Q2	2.66B
25 Q1	2.66B
24 Q4	2.66B
24 Q3	2.66B
24 Q2	2.67B
24 Q1	2.67B

Dividends (CNY)

SFOSF Dividends (CNY) by quarter
Period	Dividends (CNY)
Jul 26	0.06
Jul 25	0.04
Jul 24	0.04
Aug 23	0.06
Jun 22	0.08
Jul 21	0.07
Jul 20	0.43
Jul 19	0.36
Jul 18	0.46
Jul 17	0.05

Book Value Per Share (CNY)

SFOSF Book Value Per Share (CNY) by quarter
Period	Book Value Per Share (CNY)
26 Q2	24
26 Q1	24.13
25 Q4	23.43
25 Q3	22.95
25 Q2	22.65
25 Q1	22.85
24 Q4	22.5
24 Q3	22.23
24 Q2	22.04
24 Q1	21.55

Total Assets (CNY)

SFOSF Total Assets (CNY) by quarter
Period	Total Assets (CNY)
26 Q2	125.39B
26 Q1	122.97B
25 Q4	120.08B
25 Q3	118.12B
25 Q2	118.83B
25 Q1	117.99B
24 Q4	117.46B
24 Q3	115.26B
24 Q2	115.54B
24 Q1	113.75B

PE Ratio

SFOSF PE Ratio by quarter
Period	PE Ratio
Sep 26	8
Sep 26	9.12
Aug 26	9.14
Aug 26	9.14
Aug 26	8.12
Aug 26	9.17
Jul 26	9.18
Jul 26	9.21
Jul 26	9.21
Jul 26	9.21
Jul 26	8.47
Jun 26	8.7
Jun 26	8.67
Jun 26	8.66
Jun 26	9.3
May 26	9.31
May 26	9.34
May 26	10.44
May 26	11.21
May 26	11.25
Apr 26	11.26
Apr 26	11.67
Apr 26	11.68
Apr 26	11.78
Mar 26	15.06
Mar 26	13.51
Mar 26	13.58
Mar 26	12.97
Feb 26	14.45
Feb 26	14.55
Feb 26	14.55
Feb 26	14.62
Jan 26	16.05
Jan 26	16.07
Jan 26	15.64
Jan 26	15.66
Jan 26	15.69
Dec 25	15.92
Dec 25	16
Dec 25	19.09
Dec 25	19.14
Nov 25	19.15
Nov 25	19.23
Nov 25	19.21
Nov 25	19.28
Oct 25	19.26
Oct 25	19.27
Oct 25	19.29
Oct 25	19.31
Oct 25	19.33
Sep 25	22.73
Sep 25	20.41
Sep 25	20.43
Sep 25	18.51
Aug 25	14.93
Aug 25	15
Aug 25	15.04
Aug 25	15.04
Aug 25	17.53
Jul 25	12.79
Jul 25	12.81
Jul 25	12.79
Jul 25	12.79
Jun 25	13.52
Jun 25	13.49
Jun 25	13.53
Jun 25	13.55
May 25	13.64
May 25	13.6
May 25	13.52
May 25	13.57
May 25	13.63
Apr 25	13.66
Apr 25	13.68
Apr 25	13.67
Apr 25	13.65
Mar 25	17.84
Mar 25	17.35
Mar 25	17.32
Mar 25	18.31
Feb 25	18.44
Feb 25	18.26
Feb 25	17.18
Feb 25	16.52
Jan 25	15.53
Jan 25	15.51
Jan 25	15.68
Jan 25	15.7
Jan 25	15.67
Dec 24	18.92
Dec 24	18.91
Dec 24	18.86
Dec 24	18.85
Nov 24	21.09
Nov 24	21.1
Nov 24	21.06
Nov 24	22.37
Nov 24	18.98
Oct 24	18.97
Oct 24	18.93

Free Cash Flow Yield

SFOSF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	2.59%
Sep 26	2.27%
Aug 26	2.27%
Aug 26	2.27%
Aug 26	2.55%
Aug 26	2.26%
Jul 26	2.26%
Jul 26	2.25%
Jul 26	2.25%
Jul 26	2.25%
Jul 26	2.45%
Jun 26	2.11%
Jun 26	2.12%
Jun 26	2.12%
Jun 26	1.97%
May 26	1.97%
May 26	1.97%
May 26	1.76%
May 26	1.64%
May 26	1.63%
Apr 26	1.63%
Apr 26	1.57%
Apr 26	1.57%
Apr 26	1.56%
Mar 26	0.65%
Mar 26	0.72%
Mar 26	0.72%
Mar 26	0.75%
Feb 26	0.68%
Feb 26	0.67%
Feb 26	0.67%
Feb 26	0.67%
Jan 26	0.61%
Jan 26	0.61%
Jan 26	0.62%
Jan 26	0.62%
Jan 26	0.62%
Dec 25	0.61%
Dec 25	0.6%
Dec 25	0.51%
Dec 25	0.5%
Nov 25	0.5%
Nov 25	0.5%
Nov 25	0.5%
Nov 25	0.5%
Oct 25	0.5%
Oct 25	0.5%
Oct 25	0.5%
Oct 25	0.5%
Oct 25	0.5%
Sep 25	0.66%
Sep 25	0.73%
Sep 25	0.73%
Sep 25	0.81%
Aug 25	1%
Aug 25	1%
Aug 25	1%
Aug 25	1%
Aug 25	0.85%
Jul 25	1.17%
Jul 25	1.17%
Jul 25	1.17%
Jul 25	1.17%
Jun 25	0.81%
Jun 25	0.81%
Jun 25	0.81%
Jun 25	0.81%
May 25	0.8%
May 25	0.8%
May 25	0.81%
May 25	0.8%
May 25	0.8%
Apr 25	0.8%
Apr 25	0.8%
Apr 25	0.8%
Apr 25	0.8%
Mar 25	0.24%
Mar 25	0.24%
Mar 25	0.24%
Mar 25	0.23%
Feb 25	0.23%
Feb 25	0.23%
Feb 25	0.25%
Feb 25	0.26%
Jan 25	0.27%
Jan 25	0.27%
Jan 25	0.27%
Jan 25	0.27%
Jan 25	0.27%
Dec 24	-1.96%
Dec 24	-1.96%
Dec 24	-1.97%
Dec 24	-1.97%
Nov 24	-1.76%
Nov 24	-1.76%
Nov 24	-1.76%
Nov 24	-1.66%
Nov 24	-1.95%
Oct 24	-1.95%
Oct 24	-1.96%

Price to Sales

SFOSF Price to Sales by quarter
Period	Price to Sales
Sep 26	0.66
Sep 26	0.75
Aug 26	0.75
Aug 26	0.75
Aug 26	0.67
Aug 26	0.76
Jul 26	0.76
Jul 26	0.76
Jul 26	0.76
Jul 26	0.76
Jul 26	0.7
Jun 26	0.71
Jun 26	0.71
Jun 26	0.71
Jun 26	0.76
May 26	0.76
May 26	0.76
May 26	0.85
May 26	0.91
May 26	0.92
Apr 26	0.92
Apr 26	0.95
Apr 26	0.95
Apr 26	0.96
Mar 26	1.25
Mar 26	1.12
Mar 26	1.13
Mar 26	1.08
Feb 26	1.2
Feb 26	1.21
Feb 26	1.21
Feb 26	1.21
Jan 26	1.33
Jan 26	1.33
Jan 26	1.3
Jan 26	1.3
Jan 26	1.3
Dec 25	1.29
Dec 25	1.29
Dec 25	1.55
Dec 25	1.55
Nov 25	1.55
Nov 25	1.56
Nov 25	1.56
Nov 25	1.56
Oct 25	1.56
Oct 25	1.56
Oct 25	1.56
Oct 25	1.56
Oct 25	1.56
Sep 25	1.65
Sep 25	1.48
Sep 25	1.48
Sep 25	1.34
Aug 25	1.08
Aug 25	1.09
Aug 25	1.09
Aug 25	1.09
Aug 25	1.27
Jul 25	0.93
Jul 25	0.93
Jul 25	0.93
Jul 25	0.93
Jun 25	0.92
Jun 25	0.91
Jun 25	0.92
Jun 25	0.92
May 25	0.92
May 25	0.92
May 25	0.92
May 25	0.92
May 25	0.92
Apr 25	0.93
Apr 25	0.93
Apr 25	0.93
Apr 25	0.92
Mar 25	0.91
Mar 25	0.89
Mar 25	0.88
Mar 25	0.94
Feb 25	0.94
Feb 25	0.93
Feb 25	0.88
Feb 25	0.84
Jan 25	0.79
Jan 25	0.79
Jan 25	0.8
Jan 25	0.8
Jan 25	0.8
Dec 24	0.86
Dec 24	0.86
Dec 24	0.86
Dec 24	0.86
Nov 24	0.96
Nov 24	0.96
Nov 24	0.96
Nov 24	1.02
Nov 24	0.87
Oct 24	0.86
Oct 24	0.86

EV/EBITDA

SFOSF EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	6.14
Sep 26	6.72
Aug 26	6.73
Aug 26	6.73
Aug 26	6.2
Aug 26	6.74
Jul 26	6.75
Jul 26	6.76
Jul 26	6.76
Jul 26	6.76
Jul 26	6.38
Jun 26	6.84
Jun 26	6.82
Jun 26	6.81
Jun 26	7.14
May 26	7.14
May 26	7.16
May 26	7.71
May 26	8.08
May 26	8.11
Apr 26	8.11
Apr 26	8.31
Apr 26	8.32
Apr 26	8.37
Mar 26	11.57
Mar 26	10.77
Mar 26	10.81
Mar 26	10.5
Feb 26	11.25
Feb 26	11.31
Feb 26	11.31
Feb 26	11.34
Jan 26	12.07
Jan 26	12.08
Jan 26	11.86
Jan 26	11.87
Jan 26	11.89
Dec 25	9.92
Dec 25	9.95
Dec 25	11.42
Dec 25	11.43
Nov 25	11.44
Nov 25	11.48
Nov 25	11.47
Nov 25	11.5
Oct 25	11.49
Oct 25	11.5
Oct 25	11.51
Oct 25	11.52
Oct 25	11.52
Sep 25	12.73
Sep 25	11.68
Sep 25	11.7
Sep 25	10.83
Aug 25	9.21
Aug 25	9.24
Aug 25	9.26
Aug 25	9.26
Aug 25	10.39
Jul 25	8.25
Jul 25	8.25
Jul 25	8.25
Jul 25	8.25
Jun 25	8.04
Jun 25	8.03
Jun 25	8.05
Jun 25	8.05
May 25	8.09
May 25	8.08
May 25	8.04
May 25	8.06
May 25	8.09
Apr 25	8.1
Apr 25	8.11
Apr 25	8.11
Apr 25	8.1
Mar 25	8.26
Mar 25	8.09
Mar 25	8.09
Mar 25	8.42
Feb 25	8.46
Feb 25	8.4
Feb 25	8.04
Feb 25	7.82
Jan 25	7.48
Jan 25	7.48
Jan 25	7.53
Jan 25	7.54
Jan 25	7.53
Dec 24	9.37
Dec 24	9.37
Dec 24	9.36
Dec 24	9.35
Nov 24	10.07
Nov 24	10.07
Nov 24	10.06
Nov 24	10.47
Nov 24	9.39
Oct 24	9.39
Oct 24	9.38

Price/Operating Cashflow

SFOSF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	6.44
Sep 26	7.34
Aug 26	7.36
Aug 26	7.35
Aug 26	6.54
Aug 26	7.38
Jul 26	7.39
Jul 26	7.41
Jul 26	7.41
Jul 26	7.41
Jul 26	6.82
Jun 26	6.95
Jun 26	6.92
Jun 26	6.92
Jun 26	7.43
May 26	7.43
May 26	7.46
May 26	8.34
May 26	8.95
May 26	8.99
Apr 26	9
Apr 26	9.32
Apr 26	9.33
Apr 26	9.41
Mar 26	10.15
Mar 26	9.1
Mar 26	9.15
Mar 26	8.74
Feb 26	9.73
Feb 26	9.8
Feb 26	9.8
Feb 26	9.85
Jan 26	10.81
Jan 26	10.83
Jan 26	10.53
Jan 26	10.55
Jan 26	10.57
Dec 25	9.42
Dec 25	9.47
Dec 25	11.3
Dec 25	11.32
Nov 25	11.33
Nov 25	11.38
Nov 25	11.37
Nov 25	11.41
Oct 25	11.4
Oct 25	11.4
Oct 25	11.41
Oct 25	11.43
Oct 25	11.44
Sep 25	12.1
Sep 25	10.86
Sep 25	10.87
Sep 25	9.85
Aug 25	7.95
Aug 25	7.99
Aug 25	8
Aug 25	8.01
Aug 25	9.33
Jul 25	6.81
Jul 25	6.82
Jul 25	6.81
Jul 25	6.81
Jun 25	6.81
Jun 25	6.8
Jun 25	6.82
Jun 25	6.83
May 25	6.87
May 25	6.85
May 25	6.81
May 25	6.84
May 25	6.87
Apr 25	6.88
Apr 25	6.9
Apr 25	6.89
Apr 25	6.88
Mar 25	7.51
Mar 25	7.31
Mar 25	7.29
Mar 25	7.71
Feb 25	7.77
Feb 25	7.69
Feb 25	7.23
Feb 25	6.96
Jan 25	6.54
Jan 25	6.53
Jan 25	6.61
Jan 25	6.61
Jan 25	6.6
Dec 24	9.11
Dec 24	9.11
Dec 24	9.08
Dec 24	9.08
Nov 24	10.16
Nov 24	10.16
Nov 24	10.14
Nov 24	10.77
Nov 24	9.14
Oct 24	9.14
Oct 24	9.11

Price to Book

SFOSF Price to Book by quarter
Period	Price to Book
Sep 26	0.54
Sep 26	0.61
Aug 26	0.61
Aug 26	0.61
Aug 26	0.54
Aug 26	0.62
Jul 26	0.62
Jul 26	0.62
Jul 26	0.62
Jul 26	0.62
Jul 26	0.57
Jun 26	0.59
Jun 26	0.58
Jun 26	0.58
Jun 26	0.63
May 26	0.63
May 26	0.63
May 26	0.7
May 26	0.75
May 26	0.76
Apr 26	0.76
Apr 26	0.79
Apr 26	0.79
Apr 26	0.79
Mar 26	0.81
Mar 26	0.73
Mar 26	0.73
Mar 26	0.7
Feb 26	0.78
Feb 26	0.79
Feb 26	0.79
Feb 26	0.79
Jan 26	0.87
Jan 26	0.87
Jan 26	0.84
Jan 26	0.85
Jan 26	0.85
Dec 25	0.86
Dec 25	0.86
Dec 25	1.03
Dec 25	1.03
Nov 25	1.03
Nov 25	1.04
Nov 25	1.03
Nov 25	1.04
Oct 25	1.04
Oct 25	1.04
Oct 25	1.04
Oct 25	1.04
Oct 25	1.04
Sep 25	1.09
Sep 25	0.98
Sep 25	0.98
Sep 25	0.89
Aug 25	0.72
Aug 25	0.72
Aug 25	0.72
Aug 25	0.72
Aug 25	0.84
Jul 25	0.61
Jul 25	0.62
Jul 25	0.61
Jul 25	0.61
Jun 25	0.62
Jun 25	0.62
Jun 25	0.63
Jun 25	0.63
May 25	0.63
May 25	0.63
May 25	0.62
May 25	0.63
May 25	0.63
Apr 25	0.63
Apr 25	0.63
Apr 25	0.63
Apr 25	0.63
Mar 25	0.64
Mar 25	0.62
Mar 25	0.62
Mar 25	0.65
Feb 25	0.66
Feb 25	0.65
Feb 25	0.61
Feb 25	0.59
Jan 25	0.55
Jan 25	0.55
Jan 25	0.56
Jan 25	0.56
Jan 25	0.56
Dec 24	0.59
Dec 24	0.59
Dec 24	0.59
Dec 24	0.59
Nov 24	0.66
Nov 24	0.66
Nov 24	0.66
Nov 24	0.7
Nov 24	0.59
Oct 24	0.59
Oct 24	0.59

No video analysis for this stock yet. Request one from our team.

News: SFOSF

prnewswire.com · 6 Sep 2026

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

SHANGHAI, Sept. 6, 2026 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under which the company intends to repurchase its H-shares with an aggregate amount of up to HK$1 billion. The shares so repurchased will be cancelled or held as treasury shares. Taking concrete action to respond to market concerns, this repurchase plan demonstrates management's unwavering confidence in the company's intrinsic value. The plan has come into effect and will be implemented as soon as practicable. As a continuation of the Group's long-term value management toolkit, the company will dynamically evaluate and execute repurchases on a rolling basis in response to market conditions, establishing a normalized mechanism for shareholder returns.

AI Analysis

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Video analysis: SFOSF

News: SFOSF

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

Similar companies